感染疾病診斷市場規模、佔有率、成長分析（按產品類型、按檢測類型、按樣本類型、按疾病類型、按技術、按最終用戶、按地區）- 行業預測 2025-2032

2023 年感染疾病診斷市場規模價值 226 億美元，預計將從 2024 年的 243.2 億美元成長到 2032 年的 436.9 億美元，預測期內（2025-2032 年）的複合年成長率為 7.6%。

由於老年人口的增加（老年人更容易感染疾病）以及人們對早期診斷的認知不斷提高，預計感染疾病診斷市場將會成長。對照護現場的需求，尤其是在流行病期間，進一步推動了這一趨勢。到 2022 年，65 歲及以上人口數量預計將達到約 7.79 億，這凸顯了對有效診斷解決方案的需求，而到 2050 年，80 歲及以上人口數量預計將超過 14 億。然而，儘管許多地區的患者人數眾多，但由於監管審查力度加大，嚴格的核准流程可能會阻礙市場成長，市場仍面臨挑戰。儘管存在感染成像設備等替代方案，但體外診斷已證實的準確性和成本效益仍然具有很高的優勢，確保了其在市場上的主導地位。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 監管分析

感染疾病診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 試劑、套件及耗材
• 裝置
• 軟體和服務

感染疾病診斷市場規模（按檢測類型和複合年成長率） (2025-2032)

• 市場概覽
• 實驗室測試
• POC 測試

感染疾病診斷市場規模（按樣本類型和複合年成長率） (2025-2032)

• 市場概覽
• 血液、血清、血漿
• 尿
• 其他樣本類型

感染疾病診斷市場規模（按疾病類型和複合年成長率） (2025-2032)

• 市場概覽
• 肝炎
  • B型肝炎
  • C型肝炎
  • 其他肝炎疾病
• HIV
• 院內感染
• 蚊媒疾病
• HPV
• 披衣菌感染衣原體
• 淋病
• 結核
• 流感
• 梅毒
• 其他感染疾病

感染疾病診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 免疫診斷
• 臨床微生物學
• 聚合酵素鏈鎖反應
• 恒溫核酸增幅技術
• DNA定序與次世代定序
• DNA微陣列
• 其他技術

感染疾病診斷市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 診斷實驗室
• 醫院和診所
• 學術研究所
• 其他最終用戶

感染疾病診斷市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Abbott（US）
• bioMerieux（France）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Thermo Fisher Scientific Inc.（US）
• Hologic, Inc.（US）
• Becton, Dickinson and Company（US）
• Revvity（US）
• Qiagen（Netherlands）
• Seegene Inc.（South Korea）
• QuidelOrtho Corporation（US）
• Grifols, SA（Spain）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• OraSure Technologies（US）
• Co-Diagnostics, Inc.（US）
• Trinity Biotech（Ireland）
• Genetic Signatures Ltd.（Australia）

結論和建議

Infectious Disease Diagnostics Market size was valued at USD 22.6 billion in 2023 and is poised to grow from USD 24.32 billion in 2024 to USD 43.69 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The market for infectious disease diagnostics is poised for growth due to a rising elderly population susceptible to infections and increased awareness surrounding early diagnosis. The demand for point-of-care diagnoses, particularly amid ongoing epidemics, further fuels this trend. By 2022, approximately 779 million individuals aged 65 and older emphasized the need for effective diagnostic solutions, with projections anticipating the number of those aged 80 and above will exceed 1.4 billion by 2050. However, increasing regulatory scrutiny poses challenges, as strict approval processes potentially hinder market growth despite the large patient pool in many regions. While alternatives like infectious imaging devices exist, the proven accuracy and cost-effectiveness of in vitro diagnostics remain highly favorable, ensuring their dominance in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infectious Disease Diagnostics Market Segments Analysis

Global Infectious Disease Diagnostics Market is segmented by Product, Type of Testing, Sample Type, Disease Type, Technology, End User and region. Based on Product, the market is segmented into Reagents, Kits, And Consumables, Instruments and Software & Services. Based on Type of Testing, the market is segmented into Laboratory Testing and POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-Acquired Infections, Mosquito-Borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis and Other Infectious Diseases. Based on Technology, the market is segmented into Immunodiagnostics,Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarray and Other Technologies. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infectious Disease Diagnostics Market

The growing incidence of infectious diseases such as HIV, tuberculosis, hepatitis, and COVID-19 is significantly propelling the demand for advanced diagnostic solutions worldwide. Effective treatment hinges on accurate and timely diagnosis, which is driving innovation in diagnostic technologies, including wearable injectors that integrate these advanced capabilities. Furthermore, the heightened focus on disease surveillance and outbreak monitoring is increasing the need for rapid, accessible diagnostics, thereby fostering market growth. As healthcare systems and organizations recognize the importance of early detection in managing infectious outbreaks, the infectious disease diagnostics market continues to expand in response to these critical healthcare challenges.

Restraints in the Infectious Disease Diagnostics Market

Despite advancements in technology, the prohibitive costs associated with advanced diagnostic tools and wearable injectors continue to pose a significant challenge. In many countries, particularly those classified as low- and middle-income, the affordability and availability of these diagnostic solutions remain major obstacles, hindering their widespread implementation. This financial challenge not only affects the growth of the Infectious Disease Diagnostics Market but also intensifies existing healthcare disparities, especially in regions with limited healthcare resources. Consequently, the inability to access effective diagnostics exacerbates the struggles faced by communities in managing infectious diseases effectively.

Market Trends of the Infectious Disease Diagnostics Market

The infectious disease diagnostics market is experiencing significant growth driven by the surge in Point-of-Care Testing (POCT). This trend is characterized by the decentralization of healthcare delivery, as rapid on-demand analysis and the convenience of portable diagnostic kits become integral to patient care. The ease of use and accessibility of these tests are facilitating increased patient attendance while alleviating pressure on hospitals by enabling outpatient testing. As healthcare systems prioritize efficiency and patient-centric solutions, the demand for innovative POCT solutions is expected to escalate, reshaping the landscape of infectious disease diagnostics and enhancing overall healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis

Global Infectious Disease Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents, Kits, And Consumables
• Instruments
• Software & Services

Global Infectious Disease Diagnostics Market Size by Type of Testing & CAGR (2025-2032)

• Market Overview
• Laboratory Testing
• POC Testing

Global Infectious Disease Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Infectious Disease Diagnostics Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
• HIV
• Hospital-Acquired Infections
• Mosquito-Borne Diseases
• HPV
• Chlamydia Trachomatis
• Neisseria Gonorrhea
• Tuberculosis
• Influenza
• Syphilis
• Other Infectious Diseases

Global Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• DNA Microarray
• Other Technologies

Global Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Academic Research Institutes
• Other End Users

Global Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Co-Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetic Signatures Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations